Literature DB >> 10595955

Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy.

H Laine1, C Katoh, M Luotolahti, H Yki-Järvinen, I Kantola, A Jula, T O Takala, U Ruotsalainen, H Iida, M Haaparanta, P Nuutila, J Knuuti.   

Abstract

BACKGROUND: Patients with hypertension and left ventricular hypertrophy (LVH) are prone to develop heart failure. We tested the hypothesis that compensatory LVH is associated with normalization of myocardial oxygen consumption and that this occurs at the expense of a decrease in the ratio between cardiac work and oxygen consumption (efficiency). METHODS AND
RESULTS: Nine hypertensive men with LVH (LVH+) (age 42+/-2 years), left ventricular mass index (LVMI) 161+/-8 g/m(2), blood pressure (BP) 145+/-16/88+/-10 mm Hg (mean+/-SD); 8 hypertensive men without LVH (LVH-) (age 39+/-5 years, LVMI 107+/-15 g/m(2), BP 140+/-15/90+/-11 mm Hg); and 10 normotensive men (CONT) were studied. Myocardial blood flow, oxygen consumption, and glucose uptake were measured during euglycemic hyperinsulinemia using PET techniques. LV dimensions, volumes, and workload were determined by echocardiography, and efficiency was calculated. Myocardial workload (2.5+/-0.8 versus 3.0+/-0.6 versus 2. 3+/-0.5 mm Hg. mL. min(-1). g(-1) for CONT versus LVH- versus LVH+; P<0.05, LVH- versus LVH+), myocardial blood flow (0.84+/-0.16 versus 1.06+/-0.22 versus 0.81+/-0.09 mL. g(-1). min, respectively; P<0.05, LVH- versus other groups) and oxygen consumption (0.09+/-0.02 versus 0.14+/-0.03 versus 0.11+/-0.01 ml. g(-1). min(-1), respectively; P<0. 05, LVH- versus other groups) were increased in the LVH- group. Myocardial efficiency was reduced in the LVH+ group (18.1+/-4.1% versus 15.1+/-2.3% versus 13.5+/-1.9%, respectively; P<0.05, LVH+ versus CONT).
CONCLUSIONS: Myocardial oxygen consumption per unit weight is increased in hypertensive patients without LVH but is normal in those with LVH. The normalization of oxygen consumption via hypertrophy occurs at the expense of efficiency, which may predispose hypertensive patients with LVH to heart failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595955     DOI: 10.1161/01.cir.100.24.2425

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency.

Authors:  Lisa de las Fuentes; Pablo F Soto; Brian P Cupps; Michael K Pasque; Pilar Herrero; Robert J Gropler; Alan D Waggoner; Victor G Dávila-Román
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

2.  Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.

Authors:  Omar F AbouEzzeddine; Bradley J Kemp; Barry A Borlaug; Brian P Mullan; Atta Behfar; Sorin V Pislaru; Marat Fudim; Margaret M Redfield; Panithaya Chareonthaitawee
Journal:  Circ Heart Fail       Date:  2019-10-15       Impact factor: 8.790

3.  PET-based myocardial efficiency: Powerful yet under-utilized-now simpler than ever.

Authors:  Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2018-08-10       Impact factor: 5.952

4.  Does reduced myocardial efficiency in systemic hypertensive-hypertrophy correlate with increased left-ventricular wall thickness?

Authors:  June-Chiew Han; Carolyn J Barrett; Andrew J Taberner; Denis S Loiselle
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

5.  Attenuated right ventricular energetics evaluated using ¹¹C-acetate PET in patients with pulmonary hypertension.

Authors:  Keiichiro Yoshinaga; Hiroshi Ohira; Ichizo Tsujino; Noriko Oyama-Manabe; Lisa Mielniczuk; Rob S B Beanlands; Chietsugu Katoh; Katsuhiko Kasai; Osamu Manabe; Takahiro Sato; Satoshi Fujii; Yoichi M Ito; Yuuki Tomiyama; Masaharu Nishimura; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-11       Impact factor: 9.236

Review 6.  Radionuclide imaging of myocardial metabolism.

Authors:  Linda R Peterson; Robert J Gropler
Journal:  Circ Cardiovasc Imaging       Date:  2010-03       Impact factor: 7.792

7.  Preoperative diastolic function predicts the onset of left ventricular dysfunction following aortic valve replacement in high-risk patients with aortic stenosis.

Authors:  Marc Licker; Mustafa Cikirikcioglu; Cidgem Inan; Vanessa Cartier; Afksendyios Kalangos; Thomas Theologou; Tiziano Cassina; John Diaper
Journal:  Crit Care       Date:  2010-06-03       Impact factor: 9.097

8.  A mitochondrial mutation A4401G is involved in the pathogenesis of left ventricular hypertrophy in Chinese hypertensives.

Authors:  Hai-Yan Zhu; Shi-Wen Wang; Li Liu; Yan-Hua Li; Rui Chen; Lin Wang; C James Holliman
Journal:  Eur J Hum Genet       Date:  2008-08-13       Impact factor: 4.246

9.  Left ventricular vascular and metabolic adaptations to high-intensity interval and moderate intensity continuous training: a randomized trial in healthy middle-aged men.

Authors:  Jari-Joonas Eskelinen; Ilkka Heinonen; Eliisa Löyttyniemi; Juuso Hakala; Marja A Heiskanen; Kumail K Motiani; Kirsi Virtanen; Jussi P Pärkkä; Juhani Knuuti; Jarna C Hannukainen; Kari K Kalliokoski
Journal:  J Physiol       Date:  2016-09-27       Impact factor: 5.182

10.  The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis.

Authors:  John J Lehman; Sihem Boudina; Natasha Hausler Banke; Nandakumar Sambandam; Xianlin Han; Deanna M Young; Teresa C Leone; Richard W Gross; E Douglas Lewandowski; E Dale Abel; Daniel P Kelly
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.